Summary
The problem: Loss of function of adoptively transferred T cells for cancer immunotherapy. Adoptive cell therapy (ACT) recently became an important treatment modality for cancer. Over 400 clinical ACT trials are ongoing mainly exploiting T cells, now also expanding to other...